Accrelist Ltd., an investment holding company, engages in the medical aesthetics business in Singapore, Malaysia, and Indonesia. It operates in three segments: Mechanical Business Unit (MBU), Aesthetic Medical Services (AMS), and Financial Technology. The MBU segment offers mould design and fabrication services for consumer electronics, household appliances, automotive, and computer peripherals, as well as precision plastic injection moulding services for customers' finished products. Its AMS segment provides aesthetic services and solutions, including cosmetic dermatology and skin laser services under the under the Accrelist Medical Aesthetics brand. The Financial Technology segment offers financial services, such as crowdfunding and electronic wallet services. The company is also involved in the operation of aesthetic medical clinics that provide a range of facial treatments and aesthetic medicine; development and distribution of original design manufacturer clinical skincare products; retail sale of pharmaceutical and medical goods; online retail of skin care products; iron ore and coal trading; and manufacture and dealing in precision plastic and metal moulds. The company was formerly known as WE Holdings Ltd. and changed its name to Accrelist Ltd. in November 2016. Accrelist Ltd. is headquartered in Singapore.
Research context
ACCRELIST LTD appears in PyInvesting’s Singapore Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- SGD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
No comments yet
Start a focused discussion about QZG.SG.